<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Interleukin 1 (IL-1) alpha and beta are potent cytokines which play key roles in <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>They are controlled by IL-1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> (IL-1ra) </plain></SENT>
<SENT sid="2" pm="."><plain>AIMS: To investigate the influence of mucosal <z:mp ids='MP_0001845'>inflammation</z:mp> and IL-1ra genotype on the IL-1ra:IL-1 balance </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS AND METHODS: IL-1 alpha, IL-1 beta, and IL-1ra were measured by enzyme linked immunosorbent assay (ELISA) in biopsy specimens taken from inflamed and non-inflamed colon of 60 patients with <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> (CD), 34 with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC), 15 inflammatory controls, and 103 non-inflamed controls </plain></SENT>
<SENT sid="4" pm="."><plain>IL-1ra genotype was determined by polymerase chain reaction and gel electrophoresis </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: IL-1 alpha and IL-1 beta were significantly increased in inflamed mucosa in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) (CD: 53.5 (22.4) and 409.9 (118.7) pg/mg protein, respectively; UC: 18.9 (6.8) and 214.5 (78.2) pg/mg, respectively) and non-IBD patients (19.2 (7.4) and 281.4 (121.0) pg/mg, respectively; p &lt; 0.0001) compared with <z:mpath ids='MPATH_458'>normal</z:mpath> controls (2.8 (0.6) and 30.6 (5.6) pg/mg, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>In CD IL-1 alpha and beta were also significantly increased in non-inflamed mucosa (6.1 (1.3) pg/mg and 88.7 (17.4) pg/mg, respectively; p &lt; 0.0012) </plain></SENT>
<SENT sid="7" pm="."><plain>IL-1ra:(IL-1 alpha+beta) ratios were significantly decreased in inflamed mucosa of patients with CD (182 (45); p &lt; 0.0001), UC (425 (136); p = 0.0018) and without IBD (221 (76); p &lt; 0.0001), and in non-inflamed mucosa in CD (369 (149); p &lt; 0.0001) compared with <z:mpath ids='MPATH_458'>normal</z:mpath> controls (1307 (245); p &lt; 0.0001) </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with IL-1ra genotype 2 had slightly but significantly reduced mucosal IL-1ra concentrations (p = 0.003) </plain></SENT>
<SENT sid="9" pm="."><plain>The greatest difference was seen in colonic biopsy specimens from patients with inflamed <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Mucosal <z:mp ids='MP_0001845'>inflammation</z:mp> can modulate the balance of the IL-1:IL-1ra system in colonic mucosa </plain></SENT>
</text></document>